Repetto L - Search Results

1

Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look.

Bruzzone M, Repetto L, Chiara S, Campora E, Conte PF, Orsatti M, Vitale V, Rubagotti A, Rosso R. Bruzzone M, et al. Among authors: repetto l. Gynecol Oncol. 1990 Sep;38(3):392-5. doi: 10.1016/0090-8258(90)90080-5. Gynecol Oncol. 1990. PMID: 2227553 Clinical Trial.

2

Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer.

Repetto L, Miglietta L, Gardin G, Naso C, Giudici S, Merlini L, Queirolo P, Campora E, Pronzato P, Rosso R. Repetto L, et al. Ann Oncol. 1992 Feb;3(2):165-6. doi: 10.1093/oxfordjournals.annonc.a058135. Ann Oncol. 1992. PMID: 1606088 Free article.

3

Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer.

Chiara S, Orsatti M, Franzone P, Scarpati D, Bruzzone M, Repetto L, Vitale V, Conte PF, Rosso R. Chiara S, et al. Among authors: repetto l. Clin Oncol (R Coll Radiol). 1991 Nov;3(6):340-4. doi: 10.1016/s0936-6555(05)80590-4. Clin Oncol (R Coll Radiol). 1991. PMID: 1742234

4

Intraperitoneal chemotherapy with carboplatin and interferon alpha in the treatment of relapsed ovarian cancer: a pilot study.

Repetto L, Chiara S, Guido T, Bruzzone M, Oliva C, Ragni N, Conte PF, Rosso R. Repetto L, et al. Anticancer Res. 1991 Jul-Aug;11(4):1641-3. Anticancer Res. 1991. PMID: 1746921

5

Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: potentiation of mitoxantrone cytotoxicity.

Vigani A, Chiara S, Miglietta L, Repetto L, Conte PF, Cimoli G, Morelli L, Billi G, Parodi S, Russo P. Vigani A, et al. Among authors: repetto l. Gynecol Oncol. 1991 Apr;41(1):52-5. doi: 10.1016/0090-8258(91)90254-3. Gynecol Oncol. 1991. PMID: 2026360

6

Prognostic factors in stage IV ovarian carcinoma treated with platinum-based regimens.

Repetto L, Chiara S, Pace M, Guido T, Bruzzone M, Oliva C, Murolo C, Conte PF, Rosso R. Repetto L, et al. Tumori. 1990 Jun 30;76(3):274-7. doi: 10.1177/030089169007600313. Tumori. 1990. PMID: 2195729

7

Crossover study with cisplatin or carboplatin in advanced ovarian cancer.

Repetto L, Chiara S, Mammoliti S, Guido T, Bruzzone M, Secondo V, Donadio G, Odicino F, Ragni N, Conte PF, et al. Repetto L, et al. Gynecol Oncol. 1990 Nov;39(2):146-9. doi: 10.1016/0090-8258(90)90422-h. Gynecol Oncol. 1990. PMID: 2227588 Clinical Trial.

8

Timed sequential chemotherapy following ifosfamide-induced kinetic recruitment in refractory ovarian cancer.

Rosso R, Alama A, Repetto L, Conte PF. Rosso R, et al. Among authors: repetto l. Cancer Chemother Pharmacol. 1990;26 Suppl:S43-4. doi: 10.1007/BF00685417. Cancer Chemother Pharmacol. 1990. PMID: 2347050

9

The impact of received dose intensity on the outcome of advanced ovarian cancer.

Repetto L, Pace M, Mammoliti S, Bruzzone M, Chiara S, Oliva C, Guido T, Conte PF, Campora E, Rubagotti A, et al. Repetto L, et al. Eur J Cancer. 1993;29A(2):181-4. doi: 10.1016/0959-8049(93)90169-g. Eur J Cancer. 1993. PMID: 8422279 Clinical Trial.

10

Tamoxifen and alpha interferon in advanced breast cancer.

Miglietta L, Repetto L, Gardin G, Amoroso D, Giudici S, Naso C, Merlini L, Queirolo P, Campora E, Pronzato P, et al. Miglietta L, et al. Among authors: repetto l. J Chemother. 1991 Dec;3(6):383-6. doi: 10.1080/1120009x.1991.11739125. J Chemother. 1991. PMID: 1819622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters